GENE - Genetic Technologies Limited

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers in thousands
Total Revenue613.9881,546.3684,307.997
Cost of Revenue553.284685.0131,734.541
Gross Profit60.704861.3552,573.456
Operating Expenses
Research Development1,924.6112,191.8013,112.938
Selling General and Administrative4,779.5146,253.029,098.784
Non Recurring---
Total Operating Expenses---
Operating Income or Loss-6,643.42-7,583.466-9,638.267
Income from Continuing Operations
Total Other Income/Expenses Net366.3721,015.3791,117.575
Earnings Before Interest and Taxes-6,277.048-6,568.087-8,863.01
Interest Expense21.511203.445702.412
Income Before Tax-6,298.559-6,771.532-9,565.422
Income Tax Expense---
Minority Interest---
Net Income From Continuing Ops-6,298.559-6,771.532-9,907.74
Non-recurring Events
Discontinued Operations---
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income-6,298.559-6,771.532-9,565.422
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares-6,298.559-6,771.532-9,565.422